Pnc Financial Services Group, Inc. Ngm Biopharmaceuticals Inc Transaction History

Pnc Financial Services Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.05 - $3.37 $396 - $1,273	-378 Reduced 42.47%	512 $0
Q2 2023 Aug 11, 2023	BUY	$2.44 - $4.53 $1,405 - $2,609	576 Added 183.44%	890 $2,000
Q1 2023 May 15, 2023	BUY	$3.72 - $5.4 $178 - $259	48 Added 18.05%	314 $1,000
Q4 2022 Feb 10, 2023	BUY	$3.41 - $12.93 $593 - $2,249	174 Added 189.13%	266 $1,000
Q1 2021 May 07, 2021	BUY	$24.99 - $31.93 $2,299 - $2,937	92 New	92 $2,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.